Arterial Stiffness and Atrial Fibrillation

N/A

Waitlist Available

Led By Hon-Chi Lee, MD, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* All patients with persistent AF, scheduled for electrical cardioversion

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will help researchers learn if a test that measures stiffness in the arteries can be used to predict if a person will develop or have a recurrence of atrial fibrillation.

Eligible Conditions

Atrial Fibrillation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Recurrence of Atrial Fibrillation following cardioversion

Secondary study objectives

Heart failure

Occurrence of hospitalization

Occurrence of stroke

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Subjects with atrial fibrillationExperimental Treatment1 Intervention

Subjects with atrial fibrillation that have been clinically scheduled for an electrical cardioversion procedure will have carotid ultrasound testing done before and after the procedure

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Carotid Ultrasound

2007

Completed Phase 4

~660

0 / 1Eligibility criteria met